| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.007 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |